Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-830-3 | CAS number: 7758-02-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Neurotoxicity
Administrative data
Description of key information
The findings in a neutrotoxicological screening battery performed as part of the 90-day repeat oral dose study with ammoniumm bromide indicates that effects observed are probably reversible as evidenced in the four week recovery period at doses ≥225 mg/kg bw/day in both sexes.
Studies with sodium bromide give an NOAEL = 80 mg/kg bw/day (equivalent to 62.1 mg (Br-) /kg bw/day).
Key value for chemical safety assessment
Effect on neurotoxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- NOAEL
- 80 mg/kg bw/day
Additional information
Potassium bromide is an inorganic salt that dissociates to its composite ions in aqueous solutions at environmental pH and temperature. Comparison of the available data on the various bromide salts have shown that the bromide ion is the relevant ion for determination of the toxicological profile with simple cations such as potassium, sodium or ammonium, that are ubiquitous in nature, having little or no influence on the bromide ion properties. It is therefore justified to read-across data from other inorganic bromide salts to potassium bromide.
A neurotoxicologigal screening battery was performed as part of the 90 -day repeat oral dose study (Barton et al 2007) on ammonium bromide. The findings noted during the detailed neurotoxicity examination (included viability, clinical signs, detailed functional observations) consisted of increased limpness, decreased alertness, increases in landing foot splay and decreases in fore and hind limb grip strength. At the low dose (100 mg/kg bw/day) the findings were limited to slight limpness in 3 males; of these, only one showed the finding on more than one occasion. Functional alterations were noted in both sexes at ≥225 mg/kg bw/day. All of these effects had reversed following the 4 week recovery period, except for hind limb grip strength in females at 750 mg/kg bw/day. It was considered that all neurotoxicological effects were probably reversible.
Sodium bromide neurotoxicity in the mouse.
Motility was increased and evasion time decreased upon administration of sodium bromide while treadmill activity was decreased. Bodyweight decreases were noted for the highest three dose groups.
Multivariate analysis of all 11 variables measured indicate that no significant effects were noted for the 400 ppm dose group while for the 1200 ppm dose group significant changes were noted at a small range of time points. Higher dosages gave clear and statistically significant changes in many variables over a larger range of time points, both during and after sodium bromide administration. The effect limit based on behavioural variables and body weight therefore lies between 400 and 1200 ppm sodium bromide in mice.
Sodium bromide neurotoxicity in the rat.
The criterion of errors shows a positive relationship between the number of errors and the strength of the bromide-dosage. The criterion of time shows that the 120 mg/kg bw/day group which received the largest dose of bromide was significantly slower than each of the other groups but the other groups did not differ among themselves. All groups reached the same level of performance before the 25thday of the test. The fact suggested that in the maze-test the deleterious effects of the bromide appear in the rate of learning rather than in the performance finally attained.
LOAEL: 120 mg/kg bw/day - significantly slower navigation of the maze for rats (equivalent to 93.1 mg (Br-)/kg bw/day)
NOAEL: 80 mg/kg bw/day (equivalent to 62.1 mg (Br-) /kg bw/day)
Justification for classification or non-classification
Based on a NOAEL of 80 mg/kg bw/day, Sodium bromide is not classified as neurotoxic.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.